Caihong Zheng

No ORCID on file · 6 papers in corpus · active 2016-2025

Study types

  • article 4
  • other 1
  • review 1

Condition tags

  • endometriosis 5
other 2025
Scientific reports ·doi:10.1038/s41598-025-93146-7

Endometriosis and Recurrent Implantation Failure (RIF) are both pivotal clinical issues within the realm of reproductive medicine, sharing significant overlap in their pathophysiological mechanisms. However, research exploring the commonali…

article 2024
Acta biomaterialia ·doi:10.1016/j.actbio.2024.09.037
article 2024
Drug delivery and translational research ·doi:10.1007/s13346-024-01661-3

Mifepristone, a progesterone receptor antagonist, was initially used to terminate early pregnancy. As scientific research advanced, it emerged to be effective in the treatment of various tumors and tumor-like conditions such as endometriosi…

article 2022
Frontiers in bioengineering and biotechnology ·doi:10.3389/fbioe.2022.918368

This investigation probed endometriosis treatment using targeted nanoparticles (NPs) to modulate autophagic activity. To that end, a novel form of polymer-based NP gene delivery platform consisting of polyethyleneimine (PEI) conjugated to s…

review 2022
·doi:10.3389/fendo.2022.878069

Growth differentiation factor-8 (GDF-8) is a member of the transforming growth factor-beta superfamily. Studies in vitro and in vivo have shown GDF-8 to be involved in the physiology and pathology of ovarian reproductive functions. In vitro…

article 2016
International journal of nanomedicine ·doi:10.2147/ijn.s99692

To identify a new drug candidate for treating endometriosis which has fewer side effects, a new polymeric nanoparticle gene delivery system consisting of polyethylenimine-grafted chitosan oligosaccharide (CSO-PEI) with hyaluronic acid (HA) …